|

UnitedHealth stock gains alongside other insurers on Trump’s Dr. Oz nomination

  • UnitedHealth stock gains on Dr. Oz being named to Trump administration.
  • Trump pushed Mehmet Oz's nomination to be head of Centers for Medicare & Medicaid Services.
  • Oz is considered likely to push more Medicare Advantage plans, which benefit private-sector insurers like UNH.
  • UNH stock is testing the $600 resistance level on Wednesday.

UnitedHealth Group (UNH) stock surged more than 3% on Wednesday as investors bid up most US health insurers after President-elect Donald Trump named Dr. Oz to manage the government’s healthcare insurance unit for the elderly and indigent. 

The market is bracing for Nvidia (NVDA) earnings that arrive after the close on Wednesday, so the Dow Jones Industrial Average (DJIA), which contains both UnitedHealth and Nvidia, has slumped slightly. Only the S&P 500 has made gains among the major equity indices on Wednesday, and the NASDAQ is faring the worst, down 0.7%.

UnitedHealth stock news

Dr. Mehmet Oz, better known as Dr. Oz on television, has been a well-known face of medicine for years. Through his appearances on the Oprah Winfrey Show and elsewhere, Dr. Oz became a common personality for those seeking medical advice before then running and losing as the Republican Senate nominee for Pennsylvania in 2022.

Trained as a cardiothoracic surgeon, Oz has been named by the incoming Trump administration to head the Centers for Medicare & Medicaid Services (CMMS). This part of the government manages trillions of dollars that provide healthcare for retirees (Medicare) and those without means (Medicaid).

The basic gist here is that Dr. Oz has made positive statements in regard to Medicare Advantage plans. These plans give private insurers the ability to manage government Medicare plans for a profit.

Besides UnitedHealth, other insurers like CVS Health’s (CVS) Aetna unit, Elevance Health (ELV) and Humana (HUM) all saw their share prices climb on Wednesday.

JPMorgan pointed to postive statements that Dr. Oz made during his Senate run in 2022.

"We can expand Medicare Advantage plans," Oz said back on the campaign trail two years ago. "These plans are popular among seniors, consistently provide quality care, and have a needed incentive to keep costs low."

UnitedHealth stock chart

UNH stock is having trouble attacking the $600 level. Above there, resistance at $608 looms.

UNH daily stock chart

Premium

You have reached your limit of 3 free articles for this month.

Start your subscription and get access to all our original articles.

Subscribe to PremiumSign In

Author

Clay Webster

Clay Webster

FXStreet

Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

More from Clay Webster
Share:

Markets move fast. We move first.

Orange Juice Newsletter brings you expert driven insights - not headlines. Every day on your inbox.

By subscribing you agree to our Terms and conditions.

Editor's Picks

EUR/USD struggles for direction amid USD gains

EUR/USD is trimming part of its earlier gains, coming under some mild downside pressure near 1.1730 as the US Dollar edges higher. Markets are still digesting the Fed’s latest rate decision, while also looking ahead to more commentary from Fed officials in the sessions ahead.

GBP/USD drops to daily lows near 1.3360

Disappointing UK data weighed on the Sterling towards the end of the week, triggering a pullback in GBP/USD to fresh daily lows near 1.3360. Looking ahead, the next key event across the Channel is the BoE meeting on December 18.

Gold losses momentum, challenges $4,300

Gold now gives away some gains and disputes the key $4,300 zone per troy ounce following earlier multi-week highs. The move is being driven by expectations that the Fed will deliver further rate cuts next year, with the yellow metal climbing despite a firmer Greenback and rising US Treasury yields across the board.

Litecoin Price Forecast: LTC struggles to extend gains, bullish bets at risk

Litecoin (LTC) price steadies above $80 at press time on Friday, following a reversal from the $87 resistance level on Wednesday. Derivatives data suggests a bullish positional buildup while the LTC futures Open Interest declines, flashing a long squeeze risk.

Big week ends with big doubts

The S&P 500 continued to push higher yesterday as the US 2-year yield wavered around the 3.50% mark following a Federal Reserve (Fed) rate cut earlier this week that was ultimately perceived as not that hawkish after all. The cut is especially boosting the non-tech pockets of the market.

Aave Price Forecast: AAVE primed for breakout as bullish signals strengthen

Aave (AAVE) price is trading above $204 at the time of writing on Friday and approaching the upper boundary of its descending parallel channel; a breakout from this structure would favor the bulls.